BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
201 – 210 of 3089
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer
(
- Contribution to journal › Article
-
Mark
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer
(
- Contribution to journal › Article
-
Mark
Who should record surgical complications? Results from a third-party assessment of complications after radical cystectomy
(
- Contribution to journal › Article
-
Mark
Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series
(
- Contribution to journal › Article
-
Mark
The Biology of the Nuclear Envelope and Its Implications in Cancer Biology
(
- Contribution to journal › Scientific review
-
Mark
Genetic profiling of a chondroblastoma-like osteosarcoma/malignant phosphaturic mesenchymal tumor of bone reveals a homozygous deletion of CDKN2A, intragenic deletion of DMD, and a targetable FN1-FGFR1 gene fusion
(
- Contribution to journal › Article
-
Mark
A targeted mass spectrometry strategy for developing proteomic biomarkers : a case study of epithelial ovarian cancer
(
- Contribution to journal › Article
-
Mark
Targetable genetic alterations of TCF4 (E2-2) drive immunoglobulin expression in diffuse large B cell lymphoma
(
- Contribution to journal › Article
-
Mark
Patient satisfaction after unilateral oncoplastic volume displacement surgery for breast cancer, evaluated with the BREAST-Q™
(
- Contribution to journal › Article
-
Mark
Alpha-1-acid glycoprotein 1 is upregulated in pancreatic ductal adenocarcinoma and confers a poor prognosis
(
- Contribution to journal › Article